Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Paradas

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
BMC Medicine|March 22, 2013
Quantifiable diagnosis of muscular dystrophies and neurogenic atrophies through network analysisAurora Sáez, Eloy Rivas, Adoración Montero-Sánchez, et al.
Muscle & Nerve|May 10, 2005
X-linked Emery-Dreifuss muscular dystrophy and vacuoles: an immunohistochemical characterizationCarmen Paradas, Celedonio Márquez, Eduard Gallardo, et al.
Brain Communications|March 27, 2026
Excitotoxicity in amyotrophic lateral sclerosis: a key pathogenic mechanismSilvia Silva-Hucha, Rosendo G Hernández, Diego Baena-López, et al.
Stem Cell Research|October 17, 2017
Generation of an induced pluripotent stem cell line (CSCRMi001-A) from a patient with a new type of limb-girdle muscular dystrophy (LGMD) due to a missense mutation in POGLUT1 (Rumi)Jianbo Wu, Samuel D Hunt, Nadine Matthias, et al.
JAMA Neurology|November 20, 2013
Branching enzyme deficiency: expanding the clinical spectrumCarmen Paradas, Hasan O Akman, Carolina Ionete, et al.
Revista Espanola De Enfermedades Digestivas|January 6, 2012
Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis C patients: proof of conceptBenjamin Pardo-Yules, Rocío Gallego-Durán, Mohammed Eslam, et al.
Annals of Clinical and Translational Neurology|October 16, 2019
NOVEL intronic CAPN3 Roma mutation alters splicing causing RNA mediated decayFabiola Mavillard, Marcos Madruga-Garrido, Eloy Rivas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 23, 2012
1α,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trialNoemi De Luna, Jordi Díaz-Manera, Carmen Paradas, et al.
Brain Communications|June 19, 2026
Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiencyMichio Hirano, Caterina Garone, Richard Haas, et al.
BMC Neurology|February 2, 2023
Lessons learned from a sporadic FUSopathy in a young man: a case reportErnesto García-Roldán, Eloy Rivas-Infante, Manuel Medina-Rodríguez, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
BMC Medicine|March 22, 2013
Quantifiable diagnosis of muscular dystrophies and neurogenic atrophies through network analysisAurora Sáez, Eloy Rivas, Adoración Montero-Sánchez, et al.
Muscle & Nerve|May 10, 2005
X-linked Emery-Dreifuss muscular dystrophy and vacuoles: an immunohistochemical characterizationCarmen Paradas, Celedonio Márquez, Eduard Gallardo, et al.
Brain Communications|March 27, 2026
Excitotoxicity in amyotrophic lateral sclerosis: a key pathogenic mechanismSilvia Silva-Hucha, Rosendo G Hernández, Diego Baena-López, et al.
Stem Cell Research|October 17, 2017
Generation of an induced pluripotent stem cell line (CSCRMi001-A) from a patient with a new type of limb-girdle muscular dystrophy (LGMD) due to a missense mutation in POGLUT1 (Rumi)Jianbo Wu, Samuel D Hunt, Nadine Matthias, et al.
JAMA Neurology|November 20, 2013
Branching enzyme deficiency: expanding the clinical spectrumCarmen Paradas, Hasan O Akman, Carolina Ionete, et al.
Revista Espanola De Enfermedades Digestivas|January 6, 2012
Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis C patients: proof of conceptBenjamin Pardo-Yules, Rocío Gallego-Durán, Mohammed Eslam, et al.
Annals of Clinical and Translational Neurology|October 16, 2019
NOVEL intronic CAPN3 Roma mutation alters splicing causing RNA mediated decayFabiola Mavillard, Marcos Madruga-Garrido, Eloy Rivas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 23, 2012
1α,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trialNoemi De Luna, Jordi Díaz-Manera, Carmen Paradas, et al.
Brain Communications|June 19, 2026
Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiencyMichio Hirano, Caterina Garone, Richard Haas, et al.
BMC Neurology|February 2, 2023
Lessons learned from a sporadic FUSopathy in a young man: a case reportErnesto García-Roldán, Eloy Rivas-Infante, Manuel Medina-Rodríguez, et al.
Pageof 9